| abstract |
The present invention, among other things, uses a VLA-4 antagonist such as natalizumab to treat a stroke, eg, ischemic stroke, eg, acute ischemic stroke, and an infarct size and / or stroke, eg, ischemic stroke, eg, And methods for reducing other neurological disorders associated with acute ischemic stroke. VLA-4 antagonists such as natalizumab, for example, when administered within a certain time after the onset of stroke, have effects on infarct size and stroke, eg, ischemic stroke, eg, other related neurological disorders of acute ischemic stroke I found that it can be reduced. Also disclosed herein are products and kits for the treatment of stroke, eg, ischemic stroke, eg, acute ischemic stroke. |